1992
DOI: 10.3233/jrs-1992-35-615
|View full text |Cite
|
Sign up to set email alerts
|

Patient Compliance in Medical Practice and Clinical Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Practically, even a carefully designed treatment plan does not yield the expected results with a lack of adherence (patients’ behaviors in terms of taking medication, following diets, or executing lifestyle changes coinciding with healthcare providers’ health and medical advice). [41] In addition to the treatment effect, lack of AFU seriously affects clinical research implementation by undermining the internal and external validities of the findings [42] , attrition bias [43] , increasing the trial’s cost and duration and delaying the acquisition of important results [9] .…”
Section: Discussionmentioning
confidence: 99%
“…Practically, even a carefully designed treatment plan does not yield the expected results with a lack of adherence (patients’ behaviors in terms of taking medication, following diets, or executing lifestyle changes coinciding with healthcare providers’ health and medical advice). [41] In addition to the treatment effect, lack of AFU seriously affects clinical research implementation by undermining the internal and external validities of the findings [42] , attrition bias [43] , increasing the trial’s cost and duration and delaying the acquisition of important results [9] .…”
Section: Discussionmentioning
confidence: 99%
“…Noncompliance results from many factors, such as missed medication, failure to refill the prescription, a complicated regimen, problems with memory or vision, postictal confusion, denial of epilepsy and need for medication, fear of teratogenicity, concern about adverse effects of drugs, and cost of drugs. 48 In dealing with problem of noncompliance, Table 2 Causes of pseudoresistance [39][40][41][42][43][44][45] Causes of pseudoresistance in drug refractory epilepsy Management of Refractory Epilepsy Singh et al…”
Section: Ensure Compliancementioning
confidence: 99%
“…Diabetes [7], asthma [8], chronic kidney disease [3], obesity [9], chronic sinusitis [10], cataract [11], and amblyopia [12]. In addition to the treatment effect [13]. AFU can seriously affect clinical research, such as by undermining the internal and external validity of the findings and causing bias, increasing the cost or duration of the trial or delaying important results [14].…”
Section: Introductionmentioning
confidence: 99%